Astellas Pharma
Kalyan Nallaparaju is an experienced professional in the field of immunobiology and immuno-oncology with a focus on drug discovery and development. Currently serving as Associate Director at Astellas Pharma since November 2021, Nallaparaju previously held positions at EMD Serono, Inc. as Senior Scientist and Scientist, where significant contributions were made in establishing immune cell-based assays and phenotyping platforms for cancer therapies. Nallaparaju has also worked at Iovance Biotherapeutics as a Scientist, leading teams in the evaluation of immune checkpoint modulators and enhancing Tumor Infiltrating Lymphocytes (TIL). Academic qualifications include a Ph.D. in Immunology from the M.D. Anderson Cancer Center, complemented by a Master’s degree in Biotechnology and a Bachelor’s degree in Biotechnology from Andhra University.
This person is not in any teams
This person is not in any offices
Astellas Pharma
42 followers
Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the Americas and around the world.